Hydralazine plus isosorbide dinitrate should be added to African-American patients with New York Heart Association class III or IV heart failure with a reduced left ventricular ejection fraction (HFrEF) already receiving diuretics, beta blockers, and an ACE inhibitor or ARB [96–99, 106, 108, 109]. Here, ACE is linked to heart failure.